ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vizient Improves Visibility into Domestically Manufactured Supplies

Made in the U.S.A. Program to Bolster Supply Assurance

Vizient, Inc. today announced a new program to enhance supply assurance for its member health care providers by improving visibility of domestic manufacturing in its contract portfolio. The Made in the U.S.A. program identifies products manufactured domestically, providing a way for Vizient members to mitigate against international supply disruptions.

The program will collect data across all product categories for manufacturing that is completed in the U.S. with an initial focus on critical categories, such as personal protective equipment. Vizient members will be able to quickly identify products made in the U.S. within the Vizient catalog, and eligible suppliers will receive new opportunities to showcase their domestically manufactured products.

“Vizient members have been asking for a way to identify domestic products as they strategize short term supply solutions and emerge stronger than before the global pandemic,” said Cristina Indiveri, associate vice president, strategic programs and contract services. “Domestic manufacturing provides back-up sources and diversified product availability, bolstering provider confidence in their supply chains.”

The Made in the U.S.A. program is the latest in a series of strategic moves by Vizient to shore up supply assurance. Last year the Vizient Innovative Technology Exchange, which showcases the latest in health care technology, included a special section spotlighting contracted suppliers whose products are made in the U.S.

In 2019, Vizient launched its Novaplus Enhanced Supply (NES) Program in which contracted suppliers provide additional inventory of essential medications to mitigate disruptions and demand surge. By October 2021, the program had added 100 million units of essential medications to the U.S. market.

NES, which entails domestic warehousing of contracted products to ensure supply, was later expanded to include essential supplies, such as PPE, thermometers, and exam gloves. Since then, Vizient has contracted with multiple suppliers to bring manufacturing or warehousing on or near shore. NES has guaranteed over 540 million units of PPE since the program expanded in 2020.

Other agreements include U.S.-based manufacturing of single- and dual-head stethoscopes, disposable gowns, bouffant caps and shoe covers. Another agreement brings domestic manufacturing for millions of N95 masks for Vizient members.

“More plans are underway to strengthen supply assurance,” said Indiveri. “From providers and manufacturers to suppliers and distributors, we are working with all industry stakeholders to help ensure a resilient and stable supply chain now and in the future.”

For more information on the Made in the U.S.A. program and how Vizient is helping its members mitigate current supply disruptions, visit vizientinc.com/supplyassurance.

About Vizient, Inc.

Vizient, Inc. provides solutions and services that improve the delivery of high-value care by aligning cost, quality and market performance for more than 50% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 20% of ambulatory care providers. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $110 billion in annual purchasing volume, to improve patient outcomes and lower costs. In 2021, Vizient acquired Intalere, which expanded its footprint with ambulatory and rural acute care providers. Vizient has earned a World’s Most Ethical Company designation from the Ethisphere Institute every year since its inception. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

About Vizient Novaplus and the Novaplus Enhanced Supply Program

The private label of Vizient®, Novaplus® consistently delivers cost savings on quality medical and pharmaceutical products from well-known manufacturers. Acute and nonacute providers who choose Novaplus also enjoy improved access, price protection, dedicated support and increased efficiency. Novaplus is a critical strategy in protecting Vizient health system and hospital members from supply disruptions that can adversely affect the delivery of quality patient care.

Novaplus Enhanced Supply Program contracted suppliers provide additional inventory of essential products to mitigate supply disruptions and demand surge. Contract terms provide greater predictability and sustainability to drive continued production and supply resiliency. Production transparency requirements increase visibility to anticipate and further mitigate potential supply disruptions. By purchasing through Novaplus Enhanced Supply, health care facilities also receive expanded value and benefits built on the foundation of the industry’s longest-run private label program.

@Vizientinc announces Made in the USA program to enhance supply assurance by improving visibility of domestic manufacturing in its contract portfolio.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.